Sign in

CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company

TENAX THERAPEUTICS, INC.

Sign in to watch
Ticker
TENX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
262593535
Phone
919-855-2100
Business address
101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
Former names
OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
Open-market buys, last 90 days
$6,396,312
in 7 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$6,396,312. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ADAR1 Capital Management, LLC +$6.3M 10% owner 4 filings
  2. Doogan Declan +$102K Director 1 filing
  3. Giordano Christopher Thomas +$20K CEO 1 filing
  4. STAAB THOMAS R II +$11K Chief Financial Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2013-09-15 Jebsen Michael B Chief Financial Officer Returned to the company +14 $1.32 $18 1,621
2013-08-15 Jebsen Michael B Chief Financial Officer Returned to the company +14 $1.59 $22 1,635
2013-07-23 RALLIS CHRIS A Director Purchase · Series C 8% Convertible Preferred Stock +5 5
2013-07-23 RALLIS CHRIS A Director Purchase · Common Stock Warrants (right to buy) +2,565 2,565
2013-07-23 BLANCK RONALD R Director Purchase · Series C 8% Convertible Preferred Stock +10 10
2013-07-23 BLANCK RONALD R Director Purchase · Common Stock Warrants (right to buy) +5,129 5,129
2013-07-23 DiTonno Anthony A Director Purchase · Series C 8% Convertible Preferred Stock +5 5
2013-07-23 DiTonno Anthony A Director Purchase · Common Stock Warrants (right to buy) +2,565 2,565
2013-07-15 Jebsen Michael B Chief Financial Officer Returned to the company +14 $2.96 $41 1,649
2013-06-15 Jebsen Michael B Chief Financial Officer Returned to the company +14 $3.73 $52 1,663
2013-05-15 Jebsen Michael B Chief Financial Officer Returned to the company +279 $0.25 $70 33,534
2013-05-01 Jebsen Michael B Chief Financial Officer Grant or award +8,600 $0.25 $2K 33,813
2013-04-15 Jebsen Michael B Chief Financial Officer Returned to the company +322 $0.25 $81 25,213
2013-03-15 Jebsen Michael B Chief Financial Officer Returned to the company +324 $0.28 $91 25,535
2013-02-15 Jebsen Michael B Chief Financial Officer Returned to the company +324 $0.68 $220 25,859
2013-01-15 Jebsen Michael B Chief Financial Officer Returned to the company +324 $0.64 $207 26,183
2012-12-01 Jebsen Michael B Chief Financial Officer Returned to the company +279 $0.69 $193 26,507
2012-11-01 Jebsen Michael B Chief Financial Officer Returned to the company +279 $1.05 $293 26,786
2012-10-01 Jebsen Michael B Chief Financial Officer Returned to the company +279 $0.60 $167 27,065
2012-09-15 Jebsen Michael B Chief Financial Officer Returned to the company +279 $0.88 $246 27,344

Page 11 of 16 · 316 trades